Review
Aug 2026
Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria
This review critically examines bacteriophage-based antimicrobials, CRISPR-Cas therapeutic systems, and their emerging integration as CRISPR-armed phages, highlighting their comparative advantages, current limitations, and future potential as promising targeted antimicrobial approach platforms requiring further clinical validation.
Anjaneyulu Musini, V. Yata, S. Bukke et al.
· Molecular Biology Reports · 0 citations